A Study Evaluating Bemarituzumab in Combination With Other Anti-cancer Therapies in Subjects With Previously Untreated Advanced Gastric or Gastroesophageal Junction Cancer.
Clinical trial NCT05322577 · TERMINATED
Trial details
- NCT number
- NCT05322577
- Sponsor
- Amgen
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-17
- Primary completion
- 2025-11-21
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.